{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-083447","form_type":"8-K","ticker":"MBX","cik":"0001776111","company_name":"MBX Biosciences, Inc.","filed_at":"2025-06-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.673449+00:00","generated_at":"2026-05-19T17:23:29.895259+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"MBX Biosciences posts updated corporate presentation; no material financial or pipeline updates disclosed","bullets":["Company posted updated corporate presentation on its website on June 9, 2025.","Presentation is dated June 2025 and features the 'Precision Endocrine Peptides' tagline.","No specific data on clinical programs, financials, or guidance changes were provided in the filing.","Exhibit 99.1 (presentation) was only partially reproduced; full content not available for analysis."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-083447","json":"https://secwatch.observer/filing/0000950170-25-083447.json","markdown":"https://secwatch.observer/filing/0000950170-25-083447.md","text":"https://secwatch.observer/filing/0000950170-25-083447.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1776111/000095017025083447/0000950170-25-083447-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1776111/000095017025083447/mbx-20250609.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T17:23:29.895259+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}